On 26 November 2025 and 31 March 2026, the Agency submitted to the Commission, in accordance with Article 11(3) of Implementing Regulation (EU) No 354/2013, opinions [ECHA Opinion No UAD-C-1874461-24-00/F of 26 November 2025 and Opinion No UAD-C-1912183-29-00/F of 31 March 2026 on administrative changes to the Union authorisation of the biocidal product family ‘LANXESS CMIT/MIT biocidal product family’ https://echa.europa.eu/opinions-on-union-authorisation.] on the notified administrative changes to the Union authorisation for the biocidal product family ‘LANXESS CMIT/MIT biocidal product family’, together with a revised SPC. In these opinions, the Agency concludes that the proposed changes are administrative changes as defined in Article 3(1), point (aa), of Regulation (EU) No 528/2012 and as specified in Title 1, Sections 1 and 2, of the Annex to Implementing Regulation (EU) No 354/2013, and that, after the implementation of the changes, the conditions of Article 19 of Regulation (EU) No 528/2012 will still be met.
Recital 6, Regulation (EU) 2026/2024
In forcesince 10 Sep 2026